Resectability After First-Line FOLFIRINOX in Initially Unresectable Locally Advanced Pancreatic Cancer: A Single-Center Experience

被引:0
|
作者
Ulrich Nitsche
Patrick Wenzel
Jens T. Siveke
Rickmer Braren
Konstantin Holzapfel
Anna M. Schlitter
Christian Stöß
Bo Kong
Irene Esposito
Mert Erkan
Christoph W. Michalski
Helmut Friess
Jörg Kleeff
机构
[1] Technische Universität München,Department of Surgery, Klinikum rechts der Isar
[2] Technische Universität München,Department of Internal Medicine II, Klinikum rechts der Isar
[3] Technische Universität München,Department of Diagnostic and Interventional Radiology, Klinikum rechts der Isar
[4] Technische Universität München,Institute of Pathology
[5] Heinrich Heine University,Institute of Pathology
[6] Koc University School of Medicine,Department of Surgery
[7] University of Heidelberg,Department of Surgery
来源
Annals of Surgical Oncology | 2015年 / 22卷
关键词
Pancreatic Cancer; Pancreatic Ductal Adenocarcinoma; Tumor Regression Grade; Unresectable Pancreatic Cancer; Borderline Resectability;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1212 / 1220
页数:8
相关论文
共 50 条
  • [1] Resectability After First-Line FOLFIRINOX in Initially Unresectable Locally Advanced Pancreatic Cancer: A Single-Center Experience
    Nitsche, Ulrich
    Wenzel, Patrick
    Siveke, Jens T.
    Braren, Rickmer
    Holzapfel, Konstantin
    Schlitter, Anna M.
    Stoess, Christian
    Kong, Bo
    Esposito, Irene
    Erkan, Mert
    Michalski, Christoph W.
    Friess, Helmut
    Kleeff, Joerg
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S1212 - S1220
  • [2] FOLFIRINOX in Advanced Pancreatic Cancer: A Single-Center Experience
    Dupuis, Melissa
    Garant, Marie-Pierre
    Beaudoin, Annie
    Lemay, Frederic
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S23 - S23
  • [3] Improving Resectability and Prognosis in Initially Unresectable Locally Advanced Colon Cancer through Neoadjuvant Chemoradiotherapy: A Single-Center Retrospective Study
    Zhang, Z. T.
    Tian, X.
    Liu, Y.
    Wang, Q. X.
    Chang, H.
    Xiao, W.
    Zhang, R. X.
    Li, R. L.
    Wu, J. X.
    Lu, Z.
    Zhang, R.
    Gao, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E507 - E508
  • [4] Clinical outcomes of FOLFIRINOX in locally advanced pancreatic cancer A single center experience
    Lee, Jongchan
    Lee, Jong-chan
    Gromski, Mark A.
    Kim, Hyoung Woo
    Kim, Jinwon
    Kim, Jaihwan
    Hwang, Jin-Hyeok
    MEDICINE, 2018, 97 (50)
  • [5] Clinical outcomes of FOLFIRINOX in locally advanced pancreatic cancer: A single center experience.
    Lee, Jongchan
    Lee, Jong-Chan
    Kim, Hyoung Woo
    Kim, Jaihwan
    Hwang, Jin-Hyeok
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [6] Initial experience with neoadjuvant FOLFIRINOX as first line therapy for locally advanced pancreatic cancer
    Karachaliou, Georgia-Sofia
    Lazarou, Vasiliki
    Giannis, Dimitrios
    Astras, George
    Moris, Dimitrios
    Petrou, Athanasios
    JOURNAL OF BUON, 2020, 25 (05): : 2525 - 2527
  • [7] First-line chemotherapy with gemcitabine in advanced pancreatic cancer: a retrospective single-center analysis
    Magalhaes, H.
    Cassiano Neves, M.
    Fontes e Sousa, M.
    Machado, M.
    Marques, D.
    Faustino, C.
    Sousa, N.
    Ferreira, P.
    Raimundo, A.
    Fragoso, M.
    Luis, M.
    Sales, C.
    ANNALS OF ONCOLOGY, 2015, 26
  • [8] Irreversible electroporation for locally advanced pancreatic cancer: A single-center experience
    Tsuchiya, Takayoshi
    Sugimoto, Katsutoshi
    Kamada, Kentaro
    Fujita, Mitsuru
    Yamamoto, Kenjiro
    Matsunami, Yukitoshi
    Nagakawa, Yuichi
    Hosokawa, Yuichi
    Tsuchida, Akihiko
    Moriyasu, Fuminori
    Itoi, Takao
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 199 - 199
  • [9] A multicenter prospective phase II study of first-line modified FOLFIRINOX for unresectable advanced pancreatic cancer
    Yoshida, Kensaku
    Iwashita, Takuji
    Uemura, Shinya
    Maruta, Akinori
    Okuno, Mitsuru
    Ando, Nobuhiro
    Iwata, Keisuke
    Kawaguchi, Junji
    Mukai, Tsuyoshi
    Shimizu, Masahito
    ONCOTARGET, 2017, 8 (67) : 111346 - 111355
  • [10] Efficacy and Safety of FOLFIRINOX in Locally Advanced Pancreatic Cancer. A Single Center Experience.
    Lakatos, G.
    Petranyi, A.
    Szucs, A.
    Nehez, L.
    Harsanyi, L.
    Hegyi, P.
    Bodoky, G.
    PATHOLOGY & ONCOLOGY RESEARCH, 2017, 23 (04) : 753 - 759